The Pharmacy-Based Cost Group Model: Validating and Adjusting the Classification of Medications for Chronic Conditions to the Dutch Situation
Lamers, Leida M.
van Vliet, René C.J.A.
Health Policy 2004 April; 68(1): 113-121
Showing items related by title, author, creator and subject.
Vlieland, Thea P.M. Vliet (2002)Chronic diseases are recognized as a leading cause of mortality, morbidity, health care utilization and cost. A constant tailoring of care to the actual needs of individual patients, complexity and long duration are the ...
Longitudinal Prescribing Patterns for Psychoactive Medications in Community-Based Individuals With Developmental Disabilities: Utilization of Pharmacy Records Lott, I.T.; McGregor, M.; Engelman, L.; Touchette, P.; Tournay, A.; Sandman, C.; Fernandez, G.; Plon, L.; Walsh, D. (2004-09)
Risk Adjusted Premium Subsidies and Risk Sharing: Key Elements of the Competitive Sickness Fund Market in the Netherlands Lamers, Leida M.; van Vliet, Rene C.J.A.; van de Ven, Wynand P.M.M. (2003-07)